Michael J Glantz

11PUBLICATIONS
120CO-AUTHORS
Gene and molecular therapyPharmacogenomicsTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 15, 2026
Targeting MET and mTOR Synergistically Overcomes Adaptive Resistance in Glioblastoma.

|Jul 24, 2026
A phase 0 clinical trial to evaluate the neuropharmacological profile of posaconazole for glioblastoma.

|May 14, 2026
MGMTai: O6-methylguanine-DNA methyltransferase (MGMT) methylation prediction in isocitrate dehydrogenase (IDH)-wild type glioblastoma to direct temozolomide therapy.

|Jan 27, 2026
Fusion transcriptome landscape in glioblastoma: Incidence and therapeutic implications.

Sonikpreet Aulakh, Joanne Xiu, Shawn Kothari

|Oct 13, 2025
Intra-Ommaya reservoir administration technique affects cerebrospinal fluid drug distribution in patients with leptomeningeal metastases.

Kyle Tuohy, Alireza Mansouri, Mark Tulchinsky

|Aug 25, 2025
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM.

Alexander H Pearlman, Yuxuan Wang, Anita Kalluri

Pageof 2

Frequent Collaborators

4 joint publications

Alireza Mansouri

2 joint publications

Kyle Tuohy

2 joint publications

Theodore Nicolaides

2 joint publications

Sonikpreet Aulakh